Welcome to the Industry's Only Therapy Patient Engagement Summit
Uniting the Professionals of Different Specialties Towards the Mission of Incorporating Patient Centric Development & Access
Top companies succeed by meticulously tailoring products to customer needs. For biopharmaceutical companies to thrive, their cell & gene therapies must be just as precisely optimized for patients!
The 5th Cell & Gene Therapy Patient Engagement Summit remains the only industry focused meeting that prioritises cross functional innovation for better patient centricity, throughout the lifecycle of a therapy. And with this year’s addition of cell therapy, we’ll dive deep into different patient engagement challenges within both.
Join us as we explore how effective patient collaboration can benefit clinical development, clinical testing, regulatory approval and commercial success.
Don’t Miss Out On:
What’s New! Hear from expert speakers, like Bristol Myers Squibb, about their commercialized cell therapies, discussing tried and tested strategies to educate patients of new therapies with limited financial budgets.
Cross functional discussions amongst market access and regulatory professionals on how the industries partnership with patient organizations can alleviate regulatory and access bottlenecks, from Sarepta Therapeutics and BridgeBio.
Assessing the best practice for enhancing retention during long term follow-ups and elevating patient experiences during clinical development and treatment with Alexion Pharmaceuticals and patient organizations like Lupus Foundation of America.
Hearing valuable insights from patient organizations like SLC6A1 Connect, of their systematic process of joining a clinical trial and gain useful insights on how the industry could create better shared decision-making tools for patients.
Tackling the complex challenge of showing the commercial impact of cell and gene therapy patient engagement, by identifying new metrics and new methods of data visualization with Emily Whitehead Foundation.
Who Will You Meet?
The Summit will host Directors, Vice Presidents, Heads of Patient Engagement and allied departments, C-Level Executives and other highly regarded senior professionals all focused on implementing patient engagement across departments of their respective companies.
In addition, you will encounter C-level professionals and key leaders of patient organizations, who are open to creating long-term partnerships for the aim of creating patient centric cell and gene therapies.
What Your Peers Have to Say
"It's an exceptional meeting, one of my absolute favorites because I take home so much that I learn about the field and there's the little hints that people give that have been working in their space where, you know, pre competitive space where we can learn from each other"
Melissa Penn, Bayer
‘’For me in the space in which I work… given a really fantastic agenda, there's really not a lot of other conferences to consider’’
Amy Fisher, Spark Therapeutics
"The reason why treatment researchers and developers do this work is because patients and their families are waiting. Learning ways to walk the path to success and access together with the community who lives with rare disease every day is paramount to what matters most. As we see more and more innovative cell and gene therapies becoming available, it's important to gather together and learn from each other. Perfect timing for this Summit!"
Erin Frey, Senior Director, State Government Affairs, Ultragenyx Therapeutics
‘’I am honored to participate in a program that values Patient insights and advocacy. Now more than ever, it is vital that all stakeholders work together to get long-awaited, safe, and effective therapies to the affected patient communities. Including patients at every level (including these important discussions to be held at this summit) will doubtless lead to faster and more effective cures.’’
Kathleen O’Sullivan-Fortin, Director, Board, Treasurer & General Counsel, ALD Connect
"I’m honored to contribute to this summit, where the patient voice is recognized as a vital part of therapy development. As both an operator and advocate, I’m excited to help shape discussions that bring patient needs into the spotlight and drive more collaborative innovation"
Adam Clark, Director, Foundation Operations, Emily Whitehead Foundation
‘'The focus and collaboration at The Cell & Gene Therapy Patient Engagement Summit is unmatched. Professionals working in this nuanced space would be hard pressed to find a more valuable meeting.’’
Behtash Bahador. Director, Health Literacy, Clinical Research Programs and Services
